当前位置:首页 - 行情中心 - 金陵药业(000919) - 财务分析 - 现金流量表

金陵药业

(000919)

  

流通市值:40.79亿  总市值:40.80亿
流通股本:6.22亿   总股本:6.22亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金749,750,020.673,270,504,012.572,404,911,633.731,600,452,614.2
  收到的税费返还0642,060.7500
  收到其他与经营活动有关的现金13,437,298.4528,320,009.9350,393,090.0833,066,122.3
  经营活动现金流入小计763,187,319.123,299,466,083.252,455,304,723.811,633,518,736.5
  购买商品、接受劳务支付的现金375,637,414.761,628,792,195.611,226,370,242.59852,848,358.5
  支付给职工以及为职工支付的现金323,516,968.081,164,775,088.69927,518,392.47633,074,623.6
  支付的各项税费28,475,389.35102,950,609.4180,399,800.9550,986,013.9
  支付其他与经营活动有关的现金36,605,306.62228,738,940.41131,724,010.2180,765,441.64
  经营活动现金流出小计764,235,078.813,125,256,834.122,366,012,446.221,617,674,437.64
  经营活动产生的现金流量净额-1,047,759.69174,209,249.1389,292,277.5915,844,298.86
二、投资活动产生的现金流量:
  收回投资收到的现金127,295,075.71,146,410,563.81964,576,925.6700,814,282.78
  取得投资收益收到的现金1,988,519.9937,129,993.6116,537,266.5915,979,015.11
  处置固定资产、无形资产和其他长期资产收回的现金净额6,569,011120,522.01189,883.32179,351.55
  投资活动现金流入小计135,852,606.691,183,661,079.43981,304,075.51716,972,649.44
  购建固定资产、无形资产和其他长期资产支付的现金9,574,584.72157,867,056.5985,894,086.6473,335,097.47
  投资支付的现金431,343,089.731,335,200,0001,479,200,0001,221,200,000
  投资活动现金流出小计440,917,674.451,493,067,056.591,565,094,086.641,294,535,097.47
  投资活动产生的现金流量净额-305,065,067.76-309,405,977.16-583,790,011.13-577,562,448.03
三、筹资活动产生的现金流量:
  分配股利、利润或偿付利息支付的现金1,558,501.477,729,031.6476,394,152.347,522,456.21
  其中:子公司支付给少数股东的股利、利润677,251.410,214,127.396,650,0001,050,000
  支付其他与筹资活动有关的现金07,347,041.546,075,789-
  筹资活动现金流出小计1,558,501.485,076,073.1882,469,941.347,522,456.21
  筹资活动产生的现金流量净额-1,558,501.4-85,076,073.18-82,469,941.34-7,522,456.21
四、汇率变动对现金及现金等价物的影响-6,356.948,450.5610,367.7917,563.95
五、现金及现金等价物净增加额-307,677,685.79-220,264,350.65-576,957,307.09-569,223,041.43
  加:期初现金及现金等价物余额1,361,103,616.771,581,367,967.421,581,367,967.421,581,367,967.42
  期末现金及现金等价物余额1,053,425,930.981,361,103,616.771,004,410,660.331,012,144,925.99
补充资料:
  净利润-51,292,285.96-50,416,925.32
  资产减值准备-8,748,466.31-1,901,062.12
  固定资产和投资性房地产折旧-134,621,180.99-66,419,150.45
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-134,621,180.99-66,419,150.45
  无形资产摊销-21,886,650.43-9,839,884.56
  长期待摊费用摊销-12,546,129.66-7,142,693.92
  处置固定资产、无形资产和其他长期资产的损失-387,493.74-44,966.62
  固定资产报废损失-912,072.1--
  公允价值变动损失-108,568.42--12,013,263.09
  财务费用--4,063,493.49-2,556,969
  投资损失--30,195,899.89--11,824,341.53
  递延所得税--2,381,419.59-1,084,977.7
  其中:递延所得税资产减少--115,580-34,583.7
    递延所得税负债增加--2,265,839.59-1,050,394
  存货的减少-37,462,117.21-29,396,271.11
  经营性应收项目的减少-5,120,409.92--48,623,889.31
  经营性应付项目的增加--63,486,643.38--82,025,756.22
  其他--3,458,083.53--
  现金的期末余额-1,361,103,616.77-1,012,144,925.99
  减:现金的期初余额-1,581,367,967.42-1,581,367,967.42
  现金及现金等价物的净增加额--220,264,350.65--569,223,041.43
公告日期2026-04-282026-03-312025-10-282025-08-28
审计意见(境内)标准无保留意见
TOP↑